The U.S. And China Glucose Market size was valued at USD 6.76 billion in 2023 and is projected to reach USD 9.14 billion by 2032, exhibiting a CAGR of 4.4 % during the forecasts period. Glucose is a simple sugar and a vital carbohydrate in biology. Cells use it as the primary source of energy and a metabolic intermediate. Glucose is one of the main products of photosynthesis and starts cellular respiration in both prokaryotes and eukaryotes. Chemically, it is a monosaccharide, and it is the most abundant monosaccharide, a subcategory of carbohydrates. In humans, glucose is an essential source of energy for the body's cells. Via the bloodstream, it is transported to various organs where it is used to produce ATP through the process of cellular respiration. The body regulates blood glucose levels through insulin and glucagon, hormones produced by the pancreas, to maintain homeostasis. Glucose is also industrially synthesized from starch by hydrolysis and is widely used in the food industry. It is found naturally in fruits and honey and is often referred to as dextrose in food and nutritional contexts. As a sweet-tasting crystal, glucose is used in various food products, both for its flavor and its energy-providing properties.

Snapshot img

Continuous Glucose Monitoring (CGM) Market Size 2024-2028

The continuous glucose monitoring (CGM) market size is forecast to increase by USD 2.94 billion, at a CAGR of 6.78% between 2023 and 2028.

The market is experiencing significant growth, driven by the rising diabetic population and increasing adoption of home healthcare devices. The global diabetes prevalence continues to escalate, fueling the demand for advanced glucose monitoring solutions. CGM technology offers real-time, continuous glucose level monitoring, enabling better diabetes management and improved patient outcomes. However, challenges persist in the market. The lower diagnosis and treatment rates for diabetes, particularly in developing regions, represent a significant barrier to market expansion. Effective education and awareness campaigns, coupled with affordable pricing strategies, could help overcome this obstacle and expand the reach of CGM technology to a broader population.
By addressing these challenges and capitalizing on the growing demand for advanced diabetes management solutions, companies in the CGM market can position themselves for long-term success.

What will be the Size of the Continuous Glucose Monitoring (CGM) Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2018-2022 and forecasts 2024-2028 - in the full report.
Request Free Sample

The market is characterized by its dynamic and evolving nature, with ongoing advancements in technology and applications across various sectors of diabetes management. Interstitial fluid glucose levels are monitored in real-time through CGM systems, providing valuable data for effective diabetes management. Remote data access enables healthcare professionals to closely monitor patient glucose levels and adjust treatment plans accordingly. The correlation between CGM data and HbA1c levels is a significant focus, with calibration methods and frequency being crucial factors in ensuring sensor accuracy. Sensor miniaturization and advanced glucose sensor technology continue to drive innovation, leading to more comfortable wearable devices and improved sensor placement.

Insulin dosing is becoming increasingly personalized, with CGM data integration into mobile apps and user interface designs. Data security measures are essential to protect sensitive patient information. Skin irritation and sensor failure modes are ongoing challenges, with research focusing on improving wearable device comfort and sensor lifespan. Real-time glucose monitoring, predictive analytics, and glycemic variability are key features of advanced CGM systems. Power consumption and signal processing techniques are important considerations for extending sensor lifespan and improving data transmission protocols. Wearable sensor design and algorithm accuracy are also critical factors in ensuring user acceptance and adoption. Hyperglycemia and hypoglycemia detection are essential features of CGM systems, with hyperglycemia alerts providing timely warnings to prevent complications.

Insulin delivery systems are being integrated with CGM technology to provide closed-loop systems for automated insulin dosing. Sensor insertion methods and sensor accuracy metrics are ongoing areas of research to improve overall system performance. In summary, the CGM market is continuously unfolding, with ongoing advancements in technology, applications, and user experience. The focus is on improving sensor accuracy, user comfort, data security, and integrating CGM data into diabetes management tools for personalized care. The future of CGM technology lies in real-time monitoring, predictive analytics, and closed-loop insulin delivery systems.

How is this Continuous Glucose Monitoring (CGM) Industry segmented?

The continuous glucose monitoring (CGM) industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Component

  Sensors
  Transmitters
  Receivers


End-user

  Home care
  Hospitals
  Others


Geography

  North America

    US
    Canada


  Europe

    Germany
    UK


  APAC

    China


  Rest of World (ROW)

By Component Insights

The sensors segment is estimated to witness significant growth during the forecast period.

In the realm of diabetes management, Continuous Glucose Monitoring (CGM) systems have emerged as essential tools for effectively managing interstitial fluid glucose levels. These systems consist of a glucose sensor, transmitter, and a user interface, often integrated with mobile apps for remote data access. The sensors, which are inserted subcutaneously, continuously measure glucose levels and transmit the data to the receiver. Patients benefit from real-time glucose monitoring, enabling them

In August 2022, the glucose price per ton amounted to $644.8 (FOB, China), remaining stable against the previous month.

The size of the China Continuous Glucose Monitoring Devices Market was valued at USD 505.13 Million in 2023 and is projected to reach USD 1009.05 Million by 2032, with an expected CAGR of 10.39% during the forecast period. The China continuous glucose monitoring (CGM) devices market is expanding at a fast pace because of growing cases of diabetes and technological developments. CGM is applied for the continuous tracing of glucose level for diabetic people, which shows considerably more effective result compared to standard approaches that employ intermittent glucose measurements. These devices are of great importance more so inevaluation of complication in diabetic patients since they give trends and patterns of glucose level. It due to increasing concerns for health, advancement in technology and policies framed by governments for treatment of diabetes. Some of the trends include advancements in accurate, easy to use and cost effective CGM devices with compatibility to mobile health applications for enhanced patient interaction and insight into the data. Recent developments include: November 2023: SIBIONICS, a Chinese company, announced that it received the CE Mark for its revolutionary GS1 CGM. This significant milestone marks a momentous achievement for SIBIONICS, facilitating the distribution and utilization of this game-changing technology throughout the European market., June 2023: Medical diagnostic company Know Labs is aiming to release the world’s first commercially available non-invasive glucose monitor with the launch of its Generation (Gen) 1 device. The device houses the company’s Bio-RFID technology, which was shown to consistently and accurately measure glucose levels non-invasively in a feasibility study conducted by the Washington, US-based company across late 2022 and early 2023.. Key drivers for this market are: Rapidly Increasing Incidence and Prevalence of Diabetes, Technological Advancements in the Market. Potential restraints include: Monopolized Supply Chain and High Cost of Devices. Notable trends are: Rising Diabetes Prevalence in China.

The China Continuous Glucose Monitoring (CGM) Devices market is experiencing robust growth, projected to reach a market size of $505.13 million in 2025 and maintain a Compound Annual Growth Rate (CAGR) of 10.39% from 2025 to 2033. This expansion is fueled by several key factors. Firstly, the rising prevalence of diabetes in China, coupled with increasing awareness of the benefits of CGM technology for improved blood sugar management and reduced complications, is driving significant demand. Secondly, advancements in CGM technology, including smaller, more user-friendly devices with improved accuracy and longer battery life, are making them more accessible and appealing to patients. Government initiatives promoting better diabetes care and the expansion of healthcare infrastructure further contribute to market growth. Competition is intense, with key players such as Abbott Diabetes Care, Dexcom Inc., and Medtronic PLC holding significant market share, but also facing challenges from emerging domestic companies like Yuwell and Jiunuo Medical. The market segmentation shows a strong demand for both sensor and durable components of CGM systems. Future growth will likely depend on continued technological innovation, pricing strategies that improve affordability, and successful partnerships between manufacturers and healthcare providers to improve patient access and education. The continued high CAGR suggests substantial growth potential in the coming years. While challenges remain, such as the need for increased affordability and healthcare system integration, the long-term outlook for the China CGM market remains positive. The focus will be on expanding market penetration among the large diabetic population, particularly in underserved regions, and increasing the adoption of CGM technology within the Chinese healthcare system. The success of domestic companies will significantly influence the overall market dynamics. The market segmentation, with a focus on both sensor and durable components, indicates opportunities for specialized manufacturers and further innovation within these segments. Recent developments include: November 2023: SIBIONICS, a Chinese company, announced that it received the CE Mark for its revolutionary GS1 CGM. This significant milestone marks a momentous achievement for SIBIONICS, facilitating the distribution and utilization of this game-changing technology throughout the European market., June 2023: Medical diagnostic company Know Labs is aiming to release the world’s first commercially available non-invasive glucose monitor with the launch of its Generation (Gen) 1 device. The device houses the company’s Bio-RFID technology, which was shown to consistently and accurately measure glucose levels non-invasively in a feasibility study conducted by the Washington, US-based company across late 2022 and early 2023.. Notable trends are: Rising Diabetes Prevalence in China.

Snapshot img

Blood Glucose Monitoring System Market Size 2024-2028

The blood glucose monitoring system market size is forecast to increase by USD 3.68 billion, at a CAGR of 6.3% between 2023 and 2028.

The market is driven by the increasing availability of reimbursement for blood glucose monitoring (BGM) devices and the rising demand for continuous blood glucose monitoring (CGM) systems. The availability of reimbursement policies is a significant factor propelling market growth, as it enables patients to afford these devices and facilitates regular monitoring, leading to improved disease management. Moreover, the demand for CGM devices is surging due to their ability to provide real-time glucose level information, enabling better control and more effective management of diabetes. However, the market faces challenges, including the relatively low diagnosis and treatment rates for diabetes. Despite the advancements in BGM technology and the benefits of regular monitoring, many individuals remain undiagnosed or undertreated, limiting the potential market size. Companies in this space must focus on increasing awareness and accessibility of these devices to capitalize on the growing demand and overcome the challenges posed by low diagnosis and treatment rates.

What will be the Size of the Blood Glucose Monitoring System Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2018-2022 and forecasts 2024-2028 - in the full report.
Request Free SampleThe market is characterized by its continuous evolution, driven by advancements in technology and growing applications across various sectors, particularly in diabetes management. Cloud data storage enables real-time access to patient data, facilitating effective quality control measures and improving point-of-care testing accuracy. User interface design and optical glucose detection enhance user experience, while home glucose testing and flash glucose monitoring offer convenience and portability. Predictive analytics plays a crucial role in anticipating glucose trends, allowing for personalized medicine and proactive interventions. Sensor lifespan and calibration procedures are ongoing areas of focus, with advancements in wearable glucose trackers and mobile app connectivity streamlining user experience. Power consumption and blood sample volume are key considerations in device design, as is patient data security. Hypoglycemia and hyperglycemia alerts are essential features, ensuring timely intervention and improving glycemic control. Data logging capabilities and insulin pump integration offer comprehensive diabetes management solutions. Non-invasive glucose sensing and regulatory compliance are emerging trends, as is device miniaturization and remote patient monitoring. Glucose sensor technology continues to advance, with electrochemical biosensors and device miniaturization leading the way. Ongoing regulatory approvals and data transmission protocols ensure market growth and innovation in this dynamic and evolving market.

How is this Blood Glucose Monitoring System Industry segmented?

The blood glucose monitoring system industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments. ProductSelf monitoringContinuous glucose monitoring devicesGeographyNorth AmericaUSCanadaEuropeGermanyUKAPACChinaRest of World (ROW)

By Product Insights

The self monitoring segment is estimated to witness significant growth during the forecast period.The market in North America is experiencing significant growth due to the rising prevalence of diabetes and the increasing preference for self-monitoring devices. With advanced technologies such as optical glucose detection, predictive analytics, and mobile app connectivity, companies offer accurate, portable, and user-friendly self-monitoring blood glucose (SMBG) devices. These devices are essential for diabetes management, providing real-time glucose level readings and alerts for hypoglycemia and hyperglycemia. Quality control measures and regulatory compliance are crucial in ensuring the accuracy and reliability of these devices. Sensor lifespan and power consumption are also important considerations, with advances in glucose sensor technology leading to longer sensor life and reduced power usage. Wearable glucose trackers and continuous glucose monitoring systems are gaining popularity for their convenience and ability to provide real-time, continuous data. Calibration procedures and patient data security are essential aspects of the market, with companies implementing robust measures to ensure accurate results and protect patient privacy. Data logging capabilities and insulin pump integration are also important features, enabling patients to better m

Snapshot img

Blood Glucose Monitoring Devices Market Size 2025-2029

The blood glucose monitoring devices market size is forecast to increase by USD 10.14 billion at a CAGR of 10% between 2024 and 2029.

The market is experiencing significant growth, driven by the rising global burden of diabetes and the increasing adoption of advanced technologies such as smart watch-based apps for continuous glucose monitoring. According to the International Diabetes Foundation, approximately 463 million adults were living with diabetes in 2019, and this number is projected to reach 700 million by 2045. This growing population of diabetes patients presents a substantial market opportunity for blood glucose monitoring device manufacturers. However, the market faces challenges that could hinder its growth potential. Regulatory hurdles impact adoption, as these devices must meet stringent regulatory requirements to ensure accuracy and safety.
Additionally, supply chain inconsistencies can pose challenges, as the demand for these devices is often volatile and requires a reliable and flexible supply chain to meet patient needs effectively. To capitalize on market opportunities and navigate these challenges, companies must focus on regulatory compliance, supply chain optimization, and the development of user-friendly and accurate devices that meet the evolving needs of diabetes patients. Technological advances in this field have led to more sophisticated devices, such as continuous glucose monitoring systems, insulin syringe and pens, which offer enhanced functionality and improved patient outcomes. The hospital end-use segment supports inpatient monitoring, while home healthcare segment devices empower individuals with convenient glucose monitoring solutions. By addressing these challenges, market participants can position themselves for long-term success in the market.

What will be the Size of the Blood Glucose Monitoring Devices Market during the forecast period?

Request Free Sample

The market is experiencing significant growth, driven by the increasing prevalence of diabetes and the demand for advanced technologies to support personalized diabetes management. Patient engagement is a key trend, with diabetes prevention programs emphasizing diet and exercise, and digital health solutions enabling remote patient monitoring through the Internet of Things. Artificial intelligence and machine learning are revolutionizing data analytics, enabling early detection of diabetes complications and improving quality of life through data interpretation. Diabetes research continues to advance, with innovation in sensor calibration and cloud computing enhancing the accuracy and accessibility of blood glucose monitoring.
The market encompasses a range of essential tools including glucose meters, lancets, and test strips, crucial for managing conditions like Type 2 diabetes. Innovations like Insulin pumps and Continuous Glucose Monitoring (CGM) systems such as Eversense CGM utilize advanced sensor technologies and microminiaturization. Diabetes awareness and education programs are also crucial, leveraging digital platforms to reach larger audiences and promote lifestyle modifications. Overall, the market is dynamic and innovative, with a focus on improving diabetes management and preventing complications.

How is this Blood Glucose Monitoring Devices Industry segmented?

The blood glucose monitoring devices industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

End-user

  Hospitals
  Home care
  Diagnostic centers


Product

  SMBG
  CGM
  Lancets


Indication

  Type-2 diabetes population
  Type-1 diabetes population


Geography

  North America

    US
    Canada
    Mexico


  Europe

    France
    Germany
    Italy
    UK


  APAC

    China
    India
    Japan


  Rest of World (ROW)

By End-user Insights

The hospitals segment is estimated to witness significant growth during the forecast period.

The diabetes care market encompasses various devices and technologies used for managing diabetes, with blood glucose monitoring devices being a crucial component. These devices include blood glucose meters, continuous glucose monitoring systems like Guardian Connect and Dexcom G6, and non-invasive glucose monitoring solutions. Diabetes educators and primary care physicians often recommend these tools for individuals with diabetes, including those with type 1, type 2, and gestational diabetes. Blood glucose meters provide instant readings, while continuous glucose monitoring systems offer real-time data logging and predictive capabilities. Wearable technology, such as insulin pumps and flash glucose monitoring systems like the Freestyle Libre, enable remote monitoring and data analysis

The global glucose management supplement market is projected to increase from a valuation of US$ 9.7 billion in 2024 to US$ 17.5 billion by the end of 2034. Fact.MR’s new report has forecasted sales of glucose management supplements to rise at a CAGR of 6.1% from 2024 to 2034.

Report Attributes	Details
Glucose Management Supplement Market Size (2024E)	US$ 9.7 Billion
Forecasted Market Value (2034F)	US$ 17.5 Billion
Global Market Growth Rate (2024 to 2034)	6.1% CAGR
Canada Market Growth Rate (2024 to 2034)	4.9% CAGR
China Market Value (2034F)	US$ 3.1 Billion
North America Market Share (2024E)	24.7%
East Asia Market Share (2034F)	25.4%
Key Companies Profiled	NOW Foods; Life Extension; Natrol; Nature Made; Nature’s Bounty; Zenith Labs; Blackmores; Best Naturals; Throne; Solgar; Nutricost; Pure Encapsulations; Nutricost

Country-wise Analysis

Attribute	United States
Market Value (2024E)	US$ 1.8 Billion
Growth Rate (2024 to 2034)	5.3% CAGR
Projected Value (2034F)	US$ 3 Billion

Attribute	China
Market Value (2024E)	US$ 1.6 Billion
Growth Rate (2024 to 2034)	6.8% CAGR
Projected Value (2034F)	US$ 3.1 Billion

Category-wise Evaluation

Attribute	Capsules
Segment Value (2024E)	US$ 1 Billion
Growth Rate (2024 to 2034)	6.4% CAGR
Projected Value (2034F)	US$ 2 Billion

Attribute	Alpha Lipoic Acid
Segment Value (2024E)	US$ 2 Billion
Growth Rate (2024 to 2034)	6.1% CAGR
Projected Value (2034F)	US$ 4 Billion

As the world continues to face diabetes burden, accurate and efficient glucose monitoring becomes paramount for managing this condition. Courtesy of this, global demand for glucose monitoring devices is anticipated to surge at 10.6% CAGR during the next decade.

Attributes	Key Insights
Market Value in 2023	US$ 14.7 billion
Market Revenue in 2024	US$ 16.2 billion
Global Glucose Monitoring Device Market Size in 2034	US$ 44.6 billion
Value CAGR (2024 to 2034)	10.6%

Country-wise Insights

Countries	Value CAGR
United States	6.1%
China	16.6%
Japan	4.0%
Germany	6.7%
India	17.6%

Category-wise Insights

Product	Value CAGR
Continuous Monitoring Devices	14.7%
Self-monitoring Devices	6.7%

Indication	Value CAGR
Diabetes Type I	6.2%
Diabetes Type II	12.3%
Gestational Diabetes	2.7%

Base Year 2023 Forecast Period 2024-2028 Market Growth X.XX%*

Snapshot img

Point Of Care Glucose Testing Market Size 2024-2028

The point of care glucose testing market size is forecast to increase by USD 874.6 million at a CAGR of 4.91% between 2023 and 2028.

The market is experiencing significant growth due to the rise in diabetes cases and increasing awareness about the importance of diabetes management. According to the Centers for Disease Control and Prevention, approximately 34.2 million Americans have diabetes, making it a major public health concern. This trend is driving the demand for convenient and affordable glucose testing solutions, particularly point-of-care (POC) devices. Moreover, the focus on introducing low-cost test strips is expected to further boost market growth. However, challenges such as the need for continuous calibration and the requirement for proper training to use POC devices effectively remain.
Despite these challenges, the market is poised for continued expansion as the need for timely and accurate glucose monitoring solutions becomes increasingly crucial for effective diabetes management.

What will be the Size of the Point Of Care Glucose Testing Market During the Forecast Period?

Request Free Sample

The Point of Care (PoC) Glucose Testing market is characterized by stringent performance standards and continuous advancements in technology. Blood sample preparation plays a crucial role in ensuring accurate results, with disposable test strips and sensor drift being key considerations. Manufacturers prioritize biocompatibility testing, shelf life, and precision and repeatability to meet patient needs. Dry reagent technology, data logging capabilities, and user-friendly interfaces are trends that enhance device ergonomics and error detection systems. Reimbursement policies and device reliability are significant market drivers, with clinical trial results demonstrating the effectiveness of optical glucose sensing. Healthcare provider training and storage conditions are essential for proper use and maintaining the quality of PoC glucose testing devices.
Cloud data storage, cost-effectiveness metrics, and proficiency testing are crucial for efficient data management and maintaining regulatory compliance. Packaging requirements, response time, and wireless connectivity are other factors influencing market dynamics. Amperometric detection and automated calibration contribute to improved accuracy and ease of use, while mobile app integration and wireless connectivity enable remote monitoring and data sharing.

How is this Point Of Care Glucose Testing Industry segmented and which is the largest segment?

The point of care glucose testing industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Type

  Strips
  Lancets and lancing devices
  Meters


Geography

  North America

    US
    Canada


  Europe

    UK


  APAC

    China
    India


  Rest of World (ROW)

By Type Insights

The strips segment is estimated to witness significant growth during the forecast period.

Point-of-care glucose testing plays a crucial role in managing diabetes through the use of blood glucose meters and associated strips. These strips, made of thin plastic or paper, contain reactive enzymes like glucose oxidase that react with glucose in the blood, providing an accurate measurement. Hospitals, particularly large and medium-sized facilities, are significant users due to their advanced medical infrastructure and increased patient visits. Regulatory compliance is essential in this market, ensuring the accuracy and reliability of these devices. Interference substances, such as hematocrit levels and temperature, can impact test results, necessitating calibration procedures and quality control measures.

Advancements in sensor technology have led to the emergence of flash glucose monitoring systems and continuous glucose monitoring, enabling real-time, non-invasive monitoring. Self-monitoring devices have become popular, enabling patients to test their glucose levels at home. Data management systems facilitate the storage and interpretation of test results, while clinical validation studies ensure diagnostic accuracy and glucometer accuracy. Lancet devices and sample volume requirements are also critical considerations. Remote patient monitoring and data transmission protocols have expanded the reach of point-of-care glucose testing, enabling healthcare professionals to monitor patients from a distance. Hypoglycemia and hyperglycemia detection are essential features, with electrochemical sensors playing a significant role in result interpretation.

Temperature effects and hematocrit influence are factors that must be accounted for in the testing process. Point-of-care diagnostics, including whole blood analysis, ar

Glucose Meter Market Outlook

The global glucose meter market size was valued at approximately $12 billion in 2023 and is projected to reach around $21 billion by 2032, exhibiting a robust CAGR of 6.5% from 2024 to 2032. This growth is driven by the increasing prevalence of diabetes, rising health awareness, and technological advancements in glucose monitoring devices. As healthcare systems around the world continue to improve and become more accessible, the demand for reliable and efficient glucose monitoring solutions is expected to surge.

One of the primary growth factors for the glucose meter market is the escalating prevalence of diabetes worldwide. According to the International Diabetes Federation, there were approximately 537 million adults living with diabetes in 2021, a number expected to rise to 643 million by 2030 and 783 million by 2045. This alarming increase necessitates effective management of the condition, thereby boosting demand for glucose meters. The growing aging population, which is more prone to diabetes, also contributes significantly to market growth. Additionally, increasing awareness about diabetes management and preventive healthcare among populations further fuels the market's expansion.

Technological advancements in glucose monitoring devices are another crucial factor propelling the market. The evolution from traditional self-monitoring blood glucose meters to advanced continuous glucose monitoring (CGM) systems has revolutionized diabetes management. CGM systems provide real-time glucose level tracking, reducing the number of finger pricks required and offering better glucose control. Innovations such as non-invasive glucose monitors and the integration of glucose meters with smartphones and wearable technology are also influencing market growth positively. These advancements not only enhance patient compliance and convenience but also allow for better disease management and improved quality of life for diabetic patients.

Furthermore, supportive government initiatives and favorable reimbursement policies play a vital role in the market's growth. Governments and healthcare organizations globally are investing in diabetes care and management programs to mitigate the burden of the disease. For instance, numerous countries have implemented national diabetes plans that include subsidizing glucose monitoring devices, thus making them more accessible to a broader population. These efforts, coupled with increasing healthcare expenditure, significantly support market growth. Additionally, the rise in disposable incomes, particularly in developing regions, has made advanced diabetes management solutions more affordable, hence driving market expansion.

Regionally, North America dominates the glucose meter market owing to the high prevalence of diabetes, advanced healthcare infrastructure, and significant healthcare expenditure. Europe follows closely due to similar factors and a growing aging population. The Asia Pacific region, however, is projected to witness the highest growth rate during the forecast period. Factors such as increasing diabetes incidence, rising healthcare spending, improving healthcare infrastructure, and growing awareness about diabetes management contribute to this trend. With a large population base and increasing urbanization, countries like China and India are becoming significant markets for glucose meters. Meanwhile, Latin America and the Middle East & Africa are also expected to see notable growth, albeit at a slower pace, due to improving healthcare access and rising awareness.

Product Type Analysis

The glucose meter market is segmented based on product type into self-monitoring blood glucose (SMBG) meters and continuous glucose monitoring (CGM) meters. Each of these segments plays a critical role in diabetes management, catering to different patient needs and preferences. SMBG meters are the traditional glucose monitoring devices that require blood samples and provide readings instantly. They are widely used due to their affordability, ease of use, and reliability. These meters remain a popular choice, especially among older patients and those who may not require constant monitoring.

Continuous glucose monitoring (CGM) meters, on the other hand, represent a significant advancement in diabetes care. These devices provide real-time glucose level readings throughout the day and night, offering a more comprehensive picture of glucose trends and patte

Report Attribute/Metric	Details
Market Value in 2025	USD 1.7 billion
Revenue Forecast in 2034	USD 2.5 billion
Growth Rate	CAGR of 4.4% from 2025 to 2034
Base Year for Estimation	2024
Industry Revenue 2024	1.6 billion
Growth Opportunity	USD 0.9 billion
Historical Data	2019 - 2023
Forecast Period	2025 - 2034
Market Size Units	Market Revenue in USD billion and Industry Statistics
Market Size 2024	1.6 billion USD
Market Size 2027	1.8 billion USD
Market Size 2029	2.0 billion USD
Market Size 2030	2.1 billion USD
Market Size 2034	2.5 billion USD
Market Size 2035	2.6 billion USD
Report Coverage	Market Size for past 5 years and forecast for future 10 years, Competitive Analysis & Company Market Share, Strategic Insights & trends
Segments Covered	End-User Demographics, Device Type, Technology, Purchase Channels
Regional Scope	North America, Europe, Asia Pacific, Latin America and Middle East & Africa
Country Scope	U.S., Canada, Mexico, UK, Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Mexico, Argentina, Saudi Arabia, UAE and South Africa
Top 5 Major Countries and Expected CAGR Forecast	U.S., Germany, China, Japan, UK - Expected CAGR 3.1% - 4.0% (2025 - 2034)
Top 3 Emerging Countries and Expected Forecast	Indonesia, Turkey, Brazil - Expected Forecast CAGR 4.8% - 6.2% (2025 - 2034)
Top 2 Opportunistic Market Segments	Insulin Pumps and Integrated Diabetes Management Devices Device Type
Top 2 Industry Transitions	Transition to Non-Invasive Technologies, Adoption of AI and Big Data Analytics
Companies Profiled	Abbott Laboratories, Roche Diagnostics, Siemens Healthcare, Becton Dickinson and Company, Johnson & Johnson, Nova Biomedical, Medtronic, Bio-Rad Laboratories Inc, Bayer Healthcare, Lifescan Inc, ARKRAY Inc and Dexcom Inc
Customization	Free customization at segment, region, or country scope and direct contact with report analyst team for 10 to 20 working hours for any additional niche requirement (10% of report value)

In 2021, the market size of the diabetes medication sector in China was estimated to be about 75 billion yuan and was set to expand further in 2022. The market growth would be driven by the rise in diabetes cases, the increasing consumer health spending, as well as the positive changes in healthcare policies and programs such as Healthy China 2030.

China’s diabetes drug landscape

Currently, the antidiabetic drug industry in China is dominated by oral hypoglycemic medications (for type 2 diabetes). Acarbose has become the most popular oral antidiabetic drug, owing its effectiveness to the reduction of glucose uptake, which is particularly suitable for the high-carbohydrate Chinese diet. Another diabetes medication type is human insulin and its analogues – mainly used among all type 1 diabetes cases and some people with type 2 diabetes or gestational diabetes. Short-acting insulin aspart and long-acting glargine controlled the major Chinese market for human insulin and insulin analogues in 2018. Medical experts forecasted that glucagon-like peptide 1 receptor agonists (GLP-1 RAs) - a more convenient non-insulin option with other health benefits – would see a drastic sales growth in China.

The front runners: Novo Nordisk and Bayer

Global top diabetes drug manufacturers, like Novo Nordisk, Eli Lilly, Sanofi, and Bayer, had tapped into the massive Chinese market. When it comes to the brand popularity, the German pharmaceutical firm Bayer has been well-known with its Glucobay® - an acarbose product – winning the bestselling spot in China for the past few years. However, its rival Novo Nordisk has grabbed a significant portion of the insulin and GLP-1 market. The world leader in diabetes care earned over 12.5 billion Danish kroner (about 1.88 billion U.S. dollars) from its business in Greater China. Global heavyweights would retain their dominance in the Chinese diabetes medication sector. It would take some years for domestic players like Huangdong Medicine and Gan & Lee Pharmaceutical to gain some tractions in the market.

According to Cognitive Market Research, the global glucose monitoring devices market was valued at USD XX in 2023 and it is expected to grow at a CAGR of XX% from 2024 to 2029.

The global software engineering market will grow significantly by XX% CAGR between 2024 to 2029.
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market.
The report includes an analysis of the regional as well as market trends, key players, application areas, and market growth strategies.
Detailed analysis of Market Drivers, Restraints and Opportunities
North America dominated the market and accounted for the highest revenue of XX% in 2023 and it is projected that it will grow at a CAGR of XX% in the future.
The report consists size of the market.

Market Dynamics of Glucose Monitoring Devices

Key Drivers

Improving device synchronized data and accuracy for monitoring the glucose level drives the glucose monitoring device market

One of the most important aspects of the monitoring device is the accuracy with which it measures glucose levels. Accurate glucose monitoring is critical for successful diabetes management because it directly influences treatment decisions and patient outcomes. Several companies have developed advanced versions of conventional blood glucose monitors that are portable and minimally invasive. Many next-generation solutions include connectivity features that allow patients' health data to be captured and shared with medical professionals upon request. Companies are doing continuous innovation on the product for giving exact data to the customers. For Instance, in June 2024 Roche Holding AG receives CE mark for its AI enabled continuous glucose monitoring solution offering critical predictions to people living with 1 and type 2 diabetes n flexible insulin therapy. (source https://www.stocktitan.net/news/RHHBY/roche-receives-ce-mark-for-its-ai-enabled-continuous-glucose-i6j95ac2d9ie.html) Modern devices can now provide reliable and consistent readings, lowering the risk of complications caused by incorrect glucose measurements. Exact readings give patients more control over their blood glucose levels, resulting in fewer episodes of hyperglycemia or hypoglycemia. The development of continuous glucose monitoring (CGM) systems marks a significant technological advancement. Furthermore, accurate glucose monitoring devices are critical for healthcare providers because they allow for precise monitoring and individualized treatment plans. This can lead to more efficient resource utilization and improved patient outcomes, thereby driving market growth. As technology advances, glucose monitoring devices' accuracy is expected to improve even more, solidifying their role in effective diabetes management and expanding their global adoption.

Rising number of diabetes patients will further boost the glucose monitoring devices market

The growing incidence of diabetes among populations in both developed and undeveloped countries is leading to a large patient pool worldwide requiring blood monitoring, leading to an increase in demand for these devices among the patient population. Several factors, including rapid urbanization and the rising shift toward a sedentary lifestyle, in emerging and developed countries are primarily responsible for the growing prevalence of diabetes. For Instance, according to International Diabetes Federation (IDF) in 2021, it was estimated that around 537 million adults had diabetes, and China, India, U.S.A., Brazil and Mexico accounted for an estimated 51.6% of the global diabetes population in 2021. (source https://diabetesatlas.org/#:~:text=Diabetes%20around%20the%20world%20in%202021%3A,%2D%20and%20middle%2Dincome%20countries) A significant increase has been observed in the number of patients suffering from type-1 or insulin-dependent type 2 diabetes, which has been instrumental in surging the uptake of glucose monitoring systems globally. Thus, the presence of a large diabetic population with insulin-dependent diabetes, new product introductions by market players, and favorable reimbursement are driving demand and adoption of glucose monitoring devices

Restraints

The high cost of devices hinders the market growth

The glucose monitoring device is expensive and can be painful. Diabetes care devices do not always produce accurate results. Many hospitals and health...

The global liquid glucose market is experiencing robust growth, driven by increasing demand from the food and beverage industry, particularly in confectionery and sweet making. The market's expansion is further fueled by the rising application of liquid glucose in pharmaceuticals as a sweetener and excipient, and its use as a flavoring agent in various food products. While the precise market size for 2025 isn't provided, considering a plausible CAGR of 5% (a conservative estimate given industry growth trends) and a hypothetical 2019 market size of $5 billion, we can project a 2025 market size of approximately $6.8 billion. This projection reflects consistent growth across various segments. Key regional markets include North America, Europe, and Asia-Pacific, with significant contributions from countries like the United States, China, and India. The industry is characterized by both large multinational corporations and smaller regional players. This competitive landscape fosters innovation and drives efficiency improvements throughout the supply chain. However, the growth trajectory isn't without challenges. Fluctuations in raw material prices (primarily corn), stringent regulatory compliance requirements, and potential supply chain disruptions represent significant restraints on market expansion. The market is segmented by grade (food, pharmaceutical, industrial) and application, with food-grade liquid glucose dominating. Future growth will be significantly influenced by the ongoing innovation in food processing technologies, the increasing demand for natural and clean-label ingredients, and the expanding healthcare sector's need for pharmaceutical-grade liquid glucose. Companies are focusing on strategic partnerships, capacity expansions, and geographic diversification to capitalize on emerging market opportunities. Technological advancements in production processes, such as enzyme technology, will further contribute to increased efficiency and product quality.

The global glucose and fructose market is estimated to reach US$ 13.65 billion in 2024, as per a new report published by Fact.MR. Worldwide sales of glucose and fructose are projected to rise at a CAGR of 4.3% and reach US$ 20.78 billion by the end of 2034.

Report Attributes	Details
Glucose and Fructose Market Size (2024E)	US$ 13.65 Billion
Forecasted Market Value (2034F)	US$ 20.78 Billion
Global Market Growth Rate (2024 to 2034)	4.3% CAGR
North America Market Share (2034F)	23.2%
Mexico Market Growth Rate (2024 to 2034)	5.8% CAGR
Market Share of Bakery Segment (2034F)	22.14%
Key Companies Profiled	Archer Daniels Midland Company Tate & Lyle PLC Foodchem International Corporation Atlantic Chemicals Trading GmbH AGRABA Beteillgungs-AG Belgosuc Zukan Galam Group NOW Foods Sinofi Ingredients Hangzhou Focus Corporation Roquette Freres S.A. DuPont de Nemours, Inc. Gulshan Polyols Ltd. Global Sweeteners Holdings Limited Cargill Incorporated Penta Manufacturer Spectrum Chemical Manufacturing Corp. Nordzucker AG Teros Starch & Sweeteners

Country-wise Insights

Attribute	United States
Market Value (2024E)	US$ 2.66 Billion
Growth Rate (2024 to 2034)	3.3% CAGR
Projected Value (2034F)	US$ 3.69 Billion

Attribute	China
Market Value (2024E)	US$ 2.37 Billion
Growth Rate (2024 to 2034)	4.8% CAGR
Projected Value (2034F)	US$ 3.8 Billion

Category-wise Insights

Attribute	Fructose
Segment Value (2024E)	US$ 7.33 Billion
Growth Rate (2024 to 2034)	4.1% CAGR
Projected Value (2034F)	US$ 10.91 Billion

Attribute	Bakery
Segment Value (2024E)	US$ 3.08 Billion
Growth Rate (2024 to 2034)	4.1% CAGR
Projected Value (2034F)	US$ 4.6 Billion

This statistic depicts the market share of the global top diabetes care devices manufacturers in 2011. In that year, Medtronic from the United States had a 7.5 percent share in the total global market for diabetes care devices.

Top diabetes care devices manufacturers

Diabetes is one of the leading causes of death in the United States. In 2010, 20.8 people per 100,000 of the U.S. population died due to diabetes. In the United States, 239 billion U.S. dollars was expended in 2013 to treat diabetes. However, in China, a country with one of the largest number of diabetics in the world, only 38 billion U.S. dollars was spent on diabetes health care. The diabetes care market is expected to grow to almost 16 billion U.S. dollars in the United States by 2017.

In 2011, F.Hoffman-La Roche Ltd and LifeScan, Inc. together are considered a large part of the top diabetes care device manufacturers in the world at 15.2 percent and 14.2 percent of the global market share, respectively. Lifescan is part of the Johnson & Johnson Company and has developed glucose monitoring devices such as OneTouch Ultra for home and hospital use. About 61 percent of global diabetes care devices can be listed under the glucose monitoring device category and 24 percent under insulin delivery devices. Insulin pump therapy has vastly improved since the 1970s, with alarms for malfunction and wireless connection to meters and computers. This type of device is a widely used product for diabetics around the world.

The global diabetic sensor market is experiencing robust growth, driven by rising diabetes prevalence, technological advancements in sensor technology (like continuous glucose monitoring or CGM), and increasing demand for convenient and accurate glucose monitoring solutions. The market, currently estimated at approximately $15 billion in 2025, is projected to exhibit a compound annual growth rate (CAGR) of 5%, reaching a market value exceeding $20 billion by 2033. This growth is fueled by several key factors: the increasing adoption of CGM systems offering real-time glucose data, the development of smaller, more comfortable, and less invasive sensors, and the expanding availability of these technologies in home settings, empowering patients with better self-management capabilities. The segment breakdown reveals a significant portion of market share held by CGM sensors due to their superior accuracy and convenience compared to flash glucose sensors. Hospitals constitute a major application segment, although the home care segment is experiencing particularly rapid growth fueled by telehealth advancements and patient preference for remote monitoring. Competitive dynamics are marked by the presence of established players such as Dexcom, Abbott Diabetes Care, and Medtronic Diabetes, alongside emerging companies focused on innovative sensor technologies. Geographic analysis shows North America currently dominating the market due to higher diabetes prevalence and greater healthcare expenditure; however, Asia-Pacific is anticipated to witness the fastest growth rate in the coming years driven by increasing awareness, rising disposable income, and expanding healthcare infrastructure in countries like India and China. Market restraints include high sensor costs, potential skin irritation or allergic reactions to sensor materials, and the need for continued technological advancements to further enhance accuracy and minimize the invasiveness of sensor applications. Future growth will be shaped by the development of integrated sensor systems, improved data analytics capabilities, and the integration of these technologies within broader diabetes management platforms.

Report Attribute/Metric	Details
Market Value in 2025	USD 13.3 billion
Revenue Forecast in 2034	USD 40.5 billion
Growth Rate	CAGR of 13.2% from 2025 to 2034
Base Year for Estimation	2024
Industry Revenue 2024	11.7 billion
Growth Opportunity	USD 28.8 billion
Historical Data	2019 - 2023
Forecast Period	2025 - 2034
Market Size Units	Market Revenue in USD billion and Industry Statistics
Market Size 2024	11.7 billion USD
Market Size 2027	17.0 billion USD
Market Size 2029	21.8 billion USD
Market Size 2030	24.7 billion USD
Market Size 2034	40.5 billion USD
Market Size 2035	45.8 billion USD
Report Coverage	Market Size for past 5 years and forecast for future 10 years, Competitive Analysis & Company Market Share, Strategic Insights & trends
Segments Covered	Product Type, End-User, Technology, Sales Channel
Regional Scope	North America, Europe, Asia Pacific, Latin America and Middle East & Africa
Country Scope	U.S., Canada, Mexico, UK, Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Mexico, Argentina, Saudi Arabia, UAE and South Africa
Top 5 Major Countries and Expected CAGR Forecast	U.S., Germany, China, Japan, India - Expected CAGR 11.9% - 15.8% (2025 - 2034)
Top 3 Emerging Countries and Expected Forecast	India, Brazil, South Africa - Expected Forecast CAGR 9.2% - 13.9% (2025 - 2034)
Top 2 Opportunistic Market Segments	Homecare and Diagnostics Centers End-User
Top 2 Industry Transitions	Shift Towards Non-Invasive Technology, Emergence of Smart Biosensors
Companies Profiled	Abbott Laboratories, Roche Diagnostics, Dexcom Inc., Medtronic, LifeScan Inc., Ascensia Diabetes Care Holdings AG, Nova Biomedical, Sanofi, Arkray Inc., Omron Corporation, Sinocare Inc. and Yuwell-Jiangsu Yuyue Medical Equipment & Supply Co. Ltd.
Customization	Free customization at segment, region, or country scope and direct contact with report analyst team for 10 to 20 working hours for any additional niche requirement (10% of report value)